Padmanabhan R, Singh Rana Gopal, Unni Govindan, Desai Bhupen, Hiremath Sanjeev Kumar, Jain Vidyut, Bhawal Saikat, Gulati Sanjeev, Shete Mukesh, Nair Ramesh, Prakash Sunil, Kher Vijay, Bhattacharya Bijan
Department of Nephrology, SRM Medical College and Hospital, Chennai, Tamil Nadu, India.
Department of Medicine, Institute of Medical Sciences, Banaras Hindu University, Varanasi, India.
High Blood Press Cardiovasc Prev. 2020 Jun;27(3):215-223. doi: 10.1007/s40292-020-00385-y. Epub 2020 May 7.
Cardiovascular disease is predicted to be the largest cause of death and disability in India by 2020. Hypertension (HT), one of the main contributing factors, presents a significant public health burden. Inability to achieve adequate blood pressure (BP) control results in uncontrolled hypertension (UHT). The prevalence of UHT is high in India, with only about 9-20% of patients achieving target BP goals. Presently, there are no guidelines specific to UHT, which if left uncontrolled can lead to resistant HT, chronic kidney disease and other complications of HT. A multidisciplinary panel, comprising of specialists in cardiology, nephrology and internal medicine, was convened to address the diagnosis and management of UHT in the Indian population. The panel identified key points concerning UHT and discussed management recommendations in the Indian clinical setting.
预计到2020年,心血管疾病将成为印度死亡和残疾的最大原因。高血压(HT)是主要促成因素之一,带来了重大的公共卫生负担。无法实现足够的血压(BP)控制会导致高血压失控(UHT)。印度UHT的患病率很高,只有约9 - 20%的患者达到血压目标值。目前,尚无针对UHT的特定指南,若不加以控制,UHT可导致顽固性高血压、慢性肾病及其他高血压并发症。一个由心脏病学、肾脏病学和内科专家组成的多学科小组召开会议,以解决印度人群中UHT的诊断和管理问题。该小组确定了有关UHT的关键点,并讨论了印度临床环境中的管理建议。